United Therapeutics Corp (NASDAQ:UTHR)

Delayed Data
As of Jul 01
 +2.40 / +1.02%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 9 analysts offering 12-month price forecasts for United Therapeutics Corp have a median target of 247.00, with a high estimate of 300.00 and a low estimate of 140.00. The median estimate represents a +3.76% increase from the last price of 238.04.

Analyst Recommendations

The current consensus among 11 polled investment analysts is to Buy stock in United Therapeutics Corp. This rating has held steady since June, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Aug 03

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -13.76%
Growthannually 20.92%


Growthquarterly -0.09%
Growthannually 12.67%
Key to the earnings and sales forecast charts.